Clinical Trial Update: RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing rivaroxaban to low-molecular-weight heparin for prevention of venous thromboembolism in patients with lower limb trauma requi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: University Hospital, Angers | Conditions: Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Status: RECRUITING